Benefits and Risks of Essential Trace Elements in Chronic Kidney Disease: a Narrative Review

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2023 Jan 20

PMID 36660676

Authors

Yi Xie

Fei Liu

Xiaojing Zhang

Yanyan Jin

Qiuyu Li

Huijun Shen

Haidong Fu

Jianhua Mao

Affiliations

Soon will be listed here.

Abstract

Background And Objective: Chronic kidney disease (CKD) is an important public health concern. With the decline of renal function, CKD patients gradually progress to end-stage kidney disease and need to undergo dialysis or kidney transplantation to maintain life, bringing a heavy economic burden to the family and society. Therefore, it is necessary to effectively prevent and delay the progression of CKD. Essential trace elements play an indispensable role in CKD, and the objective of this study is to systematically review their benefits in the disease and summarize the risks of their excess.

Methods: The keywords "trace elements", "chronic kidney disease", "dialysis", "inflammation", and "fibrosis" and their combinations were used to search for relevant literature published in the PubMed database and Web of Science. We then summarized the role of trace element abnormalities in CKD patients in anemia, oxidative stress, inflammation, and chronic fibrosis, and the risk of their excess.

Key Content And Findings: Imbalance of essential trace elements is a common complication of CKD and a risk factor for CKD progression, cardiovascular events, and death. This article reviews the effects of essential trace elements (iron, zinc, selenium, copper, iodine, and manganese) on CKD. We analyze literature and discuss the advantages and disadvantages of various essential trace elements.

Conclusions: Research shows CKD patients have an imbalance of essential trace elements, and treatment based on these is an important direction for future exploration. A knowledge of the homeostasis of trace elements is important to improving the prognosis of CKD patients and delaying the progression of the disease.

Citing Articles

Role of urinary trace elements in diabetic kidney disease: a cross-sectional analysis.

Gao T, Lv J, Lu L, Guo L, Tang W, Shao F BMJ Open Diabetes Res Care. 2024; 12(6.

PMID: 39706673 PMC: 11667472. DOI: 10.1136/bmjdrc-2024-004454.

Advanced Low-Cost Technology for Assessing Metal Accumulation in the Body of a Metropolitan Resident Based on a Neural Network Model.

Tunakova Y, Novikova S, Valiev V, Danilaev M, Faizullin R Sensors (Basel). 2024; 24(22).

PMID: 39598936 PMC: 11598805. DOI: 10.3390/s24227157.

Associations between serum mineral concentrations and mortality by renal function in the Ludwigshafen Risk and Cardiovascular Health Study.

Moissl A, Delgado G, Kleber M, Kramer B, Marz W, Lorkowski S Sci Rep. 2024; 14(1):28581.

PMID: 39562674 PMC: 11577029. DOI: 10.1038/s41598-024-79575-w.

Evaluation of lipid profile, liver function enzymes, and trace elements in Iraqi diabetic nephropathy patients.

Zaid M, Al-Fartusie F, Pazhang Y, Kader S Biometals. 2024; 37(6):1565-1574.

PMID: 39179936 DOI: 10.1007/s10534-024-00626-w.

Habitual Iron Supplementation Associated with Elevated Risk of Chronic Kidney Disease in Individuals with Antihypertensive Medication.

Ma X, Lv J, Zhang S, Zhang X, Lin X, Li S Nutrients. 2024; 16(14).

PMID: 39064798 PMC: 11279651. DOI: 10.3390/nu16142355.

References

Gammoh N, Rink L . Zinc in Infection and Inflammation. Nutrients. 2017; 9(6). PMC: 5490603. DOI: 10.3390/nu9060624. View

Jomova K, Valko M . Advances in metal-induced oxidative stress and human disease. Toxicology. 2011; 283(2-3):65-87. DOI: 10.1016/j.tox.2011.03.001. View

Miller K, Caton J, Finley J . Manganese depresses rat heart muscle respiration. Biofactors. 2007; 28(1):33-46. DOI: 10.1002/biof.5520280104. View

Rovetta F, Catalani S, Steimberg N, Boniotti J, Gilberti M, Mariggio M . Organ-specific manganese toxicity: a comparative in vitro study on five cellular models exposed to MnCl(2). Toxicol In Vitro. 2006; 21(2):284-92. DOI: 10.1016/j.tiv.2006.08.010. View

Chen J, Jiang Y, Shi H, Peng Y, Fan X, Li C . The molecular mechanisms of copper metabolism and its roles in human diseases. Pflugers Arch. 2020; 472(10):1415-1429. DOI: 10.1007/s00424-020-02412-2. View

Parkkinen J, von Bonsdorff L, Peltonen S, Gronhagen-Riska C, Rosenlof K . Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration. Nephrol Dial Transplant. 2000; 15(11):1827-34. DOI: 10.1093/ndt/15.11.1827. View

Kim S, Kang S, Joo J, Han S, Shin H, Nam B . Characterization of ferroptosis in kidney tubular cell death under diabetic conditions. Cell Death Dis. 2021; 12(2):160. PMC: 7870666. DOI: 10.1038/s41419-021-03452-x. View

Fukushima T, Horike H, Fujiki S, Kitada S, Sasaki T, Kashihara N . Zinc deficiency anemia and effects of zinc therapy in maintenance hemodialysis patients. Ther Apher Dial. 2009; 13(3):213-9. DOI: 10.1111/j.1744-9987.2009.00656.x. View

Leal V, Lobo J, Stockler-Pinto M, Farage N, Velarde G, Fouque D . Zinc-α2-glycoprotein: is there association between this new adipokine and body composition in hemodialysis patients?. Ren Fail. 2012; 34(9):1062-7. DOI: 10.3109/0886022X.2012.712859. View

10.

Kung W, Shih C, Lee C, Lin C . The Divalent Elements Changes in Early Stages of Chronic Kidney Disease. Biol Trace Elem Res. 2017; 185(1):30-35. DOI: 10.1007/s12011-017-1228-3. View

11.

Liu Z, Tan R, Liu Y . The Many Faces of Matrix Metalloproteinase-7 in Kidney Diseases. Biomolecules. 2020; 10(6). PMC: 7356035. DOI: 10.3390/biom10060960. View

12.

Chen Y, Feng H, Jeng S . Zinc Supplementation Stimulates Red Blood Cell Formation in Rats. Int J Mol Sci. 2018; 19(9). PMC: 6165144. DOI: 10.3390/ijms19092824. View

13.

Darroudi S, Saberi-Karimian M, Tayefi M, Tayefi B, Khashyarmanesh Z, Fereydouni N . Association Between Hypertension in Healthy Participants and Zinc and Copper Status: a Population-Based Study. Biol Trace Elem Res. 2018; 190(1):38-44. DOI: 10.1007/s12011-018-1518-4. View

14.

Pushpakumar S, Ren L, Kundu S, Gamon A, Tyagi S, Sen U . Toll-like Receptor 4 Deficiency Reduces Oxidative Stress and Macrophage Mediated Inflammation in Hypertensive Kidney. Sci Rep. 2017; 7(1):6349. PMC: 5526876. DOI: 10.1038/s41598-017-06484-6. View

15.

Thompson S, Tonelli M . Selenium for malnutrition in hemodialysis patients: have we considered all of the elements?. Nephrol Dial Transplant. 2012; 28(3):498-500. DOI: 10.1093/ndt/gfs286. View

16.

Jiang Y, Zheng W . Cardiovascular toxicities upon manganese exposure. Cardiovasc Toxicol. 2005; 5(4):345-54. PMC: 3980854. DOI: 10.1385/ct:5:4:345. View

17.

Bogye G, Tompos G, Alfthan G . Selenium depletion in hemodialysis patients treated with polysulfone membranes. Nephron. 2000; 84(2):119-23. DOI: 10.1159/000045558. View

18.

Sonnweber T, Theurl I, Seifert M, Schroll A, Eder S, Mayer G . Impact of iron treatment on immune effector function and cellular iron status of circulating monocytes in dialysis patients. Nephrol Dial Transplant. 2010; 26(3):977-87. DOI: 10.1093/ndt/gfq483. View

19.

Issad B, Ghali N, Beaudreuil S, Griuncelli M, Cohen Y, Rostoker G . Hepatic Iron Load at Magnetic Resonance Imaging Is Normal in Most Patients Receiving Peritoneal Dialysis. Kidney Int Rep. 2017; 2(6):1219-1222. PMC: 5733676. DOI: 10.1016/j.ekir.2017.07.005. View

20.

Zitouni K, Steyn M, Lyka E, Kelly F, Cook P, Chis Ster I . Derepression of glomerular filtration, renal blood flow and antioxidant defence in patients with type 2 diabetes at high-risk of cardiorenal disease. Free Radic Biol Med. 2020; 161:283-289. DOI: 10.1016/j.freeradbiomed.2020.10.005. View